Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Cipepofol (HSK3486, CYPSEDO) has received FDA marketing approval as an intravenous (IV) general anesthetic.
There is no EMA marketing authorization for Cipepofol; Europe is in the "planning/intent" stage. The approved indication is for use in anesthesia in adults, specifically for the induction of general anesthesia.The approval is for Cipepofol as a monotherapy IV general anesthetic, similar to propofol (1)
(1) [FDA Approves Haisco's Cypsedo for IV Anesthesia](https://allsci.com/news/approvals/fda-approves-haisc…